Detailed view for Tb11.v5.0190

Basic information

TDR Targets ID: 321685
Trypanosoma brucei, protein kinase, putative

Source Database / ID:  TriTrypDB  GeneDB

pI: 7.7412 | Length (AA): 494 | MW (Da): 54968 | Paralog Number: 2

Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0

Druggability Group : DG4

Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable

Pfam domains

PF00069   Protein kinase domain
PF00169   PH domain

Gene Ontology

Mouse over links to read term descriptions.
GO:0005524   ATP binding  
GO:0004713   protein tyrosine kinase activity  
GO:0004674   protein serine/threonine kinase activity  
GO:0004672   protein kinase activity  
GO:0006468   protein amino acid phosphorylation  

Metabolic Pathways

This gene is not mapped to any metabolic pathway in KEGG.

Structural information

Modbase 3D models:

No model available for this protein in Modbase.

PDB Structures:

No structure availble in the PDB for this protein

Expression

Upregulation Percent Ranking Stage Dataset
Lower 20-40% percentile Procyclic, Bloodstream Form. Siegel TN
Show/Hide expression data references
  • Siegel TN Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites.

Orthologs

Ortholog group members (OG5_135887)

Species Accession Gene Product
Leishmania braziliensis LbrM.35.1660   hypothetical protein, conserved,nima-related protein kinase, putative
Leishmania donovani LdBPK_361580.1   hypothetical protein, conserved
Leishmania infantum LinJ.36.1580   hypothetical protein, conserved,nima-related protein kinase, putative
Leishmania major LmjF.36.1520   hypothetical protein, conserved,nima-related protein kinase, putative
Leishmania mexicana LmxM.36.1520   hypothetical protein, conserved,nima-related protein kinase, putative
Trypanosoma brucei gambiense Tbg972.10.7220   protein kinase, putative,(OTHER) NEK family, HsNEK1-like
Trypanosoma brucei gambiense Tbg972.10.7270   protein kinase, putative
Trypanosoma brucei Tb11.v5.0190   protein kinase, putative
Trypanosoma brucei Tb927.10.5930   NEK family Serine/threonine-protein kinase, putative
Trypanosoma brucei Tb927.10.5940   NEK family Serine/threonine-protein kinase, putative
Trypanosoma congolense TcIL3000_10_4970   protein kinase, putative
Trypanosoma cruzi TcCLB.509599.150   Serine/threonine-protein kinase NEK17, putative
Trypanosoma cruzi TcCLB.509599.130   NEK family Serine/threonine-protein kinase, putative
Trypanosoma cruzi TcCLB.506327.90   Serine/threonine-protein kinase NEK17, putative
Trypanosoma cruzi TcCLB.463451.10   NEK family Serine/threonine-protein kinase, putative

Essentiality

Tb11.v5.0190 has direct evidence of essentiality
Gene/Ortholog Organism Phenotype Source Study
Tb927.10.5950 this record Trypanosoma brucei no significant loss or gain of fitness in bloodstream forms (3 days) alsford
Tb927.10.5950 this record Trypanosoma brucei significant gain of fitness in bloodstream forms (6 days) alsford
Tb927.10.5950 this record Trypanosoma brucei no significant loss or gain of fitness in procyclic forms alsford
Tb927.10.5950 this record Trypanosoma brucei significant gain of fitness in differentiation of procyclic to bloodstream forms alsford
Tb927.10.5940 Trypanosoma brucei no significant loss or gain of fitness in bloodstream forms (3 days) alsford
Tb927.10.5940 Trypanosoma brucei significant loss of fitness in bloodstream forms (6 days) alsford
Tb927.10.5940 Trypanosoma brucei no significant loss or gain of fitness in procyclic forms alsford
Tb927.10.5940 Trypanosoma brucei no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms alsford
Show/Hide essentiality data references
  • plasmo Functional Profiling of a Plasmodium Genome Reveals an Abundance of Essential Genes. Bushell, Ellen, et al. "Functional profiling of a Plasmodium genome reveals an abundance of essential genes." Cell 170.2 (2017): 260-272.
  • blattner Systematic mutagenesis of the E. coli (MG1655) genome J Bacteriol 2004, 186:4921-4930
  • shigen Profiling of E. coli Chromosome (PEC) National Institute of Genetics, Japan
  • yeastgenome Systematic deletion of yeast genes Saccharomyces Genome Database
  • goodall The Essential Genome of Escherichia coli K-12 (Transposon directed high-throughput mutagenesis) Goodall, Emily CA, et al. "The essential genome of Escherichia coli K-12." mBio 9.1 (2018): e02096-17.
  • keio Systematic single-gene knock-out mutants of E. coli K12 The Keio Collection
  • gerdes Experimental determination and system-level analysis of essential genes in E. coli MG1655 Gerdes et al., J Bacteriol. 2003 185:5673-84
  • sidik A Genome-wide CRISPR Screen in Toxoplasma Identifies Essential Apicomplexan Genes. Sidik, Saima M., et al. "A genome-wide CRISPR screen in toxoplasma identifies essential apicomplexan genes." Cell 166.6 (2016): 1423-1435.
  • wormbase C. elegans RNAi experiments WormBase web site, http://www.wormbase.org, release WS170
  • nmpdr Genome-scale essentiality datasets from published studies (M. tuberculosis) National Microbial Pathogen Data Resource
  • alsford High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome Genome Res 2011, 21:915-924
  • neb C. elegans RNAi phenotypes Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs

Phenotypes and Validation (curated)

Annotated phenotypes:

Affected Entity Phenotypic quality Occurs in Occurs at Evidence Observed in Drugs/Inhibitors
cell proliferation (GO:0008283) normal (PATO:0000461) bloodstream stage trypomastigotes (PLO:0027) inferred from RNAi experiment (ECO:0000019) No drug identifiers listed for this gene.
Annotator: fernan@iib.unsam.edu.ar. Comment: normal cell proliferation (no significant loss or gain of fitness) in bloodstream forms (stage 3 days). References: 21363968
cell proliferation (GO:0008283) increased (PATO:0000470) bloodstream stage trypomastigotes (PLO:0027) inferred from RNAi experiment (ECO:0000019) No drug identifiers listed for this gene.
Annotator: fernan@iib.unsam.edu.ar. Comment: increased cell proliferation (significant gain of fitness) in bloodstream forms (stage 6 days). References: 21363968
cell proliferation (GO:0008283) normal (PATO:0000461) procyclic (PLO:0034) inferred from RNAi experiment (ECO:0000019) No drug identifiers listed for this gene.
Annotator: fernan@iib.unsam.edu.ar. Comment: normal cell proliferation (no significant loss or gain of fitness) in procyclic forms . References: 21363968
cell proliferation (GO:0008283) increased (PATO:0000470) procyclic (PLO:0034) inferred from RNAi experiment (ECO:0000019) No drug identifiers listed for this gene.
Annotator: fernan@iib.unsam.edu.ar. Comment: increased cell proliferation (significant gain of fitness) in differentiation of procyclic to bloodstream forms . References: 21363968

In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.

In any case, if you have information about papers containing relevant validation data for this target, please contact us.


Annotated validation

No validation data for this target

Associated compounds / Druggability

Known modulators for this target

No chemical compounds associated to this gene

Predicted associations

By orthology with druggable targets
Non orthologous druggable targets
By sequence similarity to non orthologous druggable targets
Species Target Length Identity Alignment span Linked Drugs Reference
Oryctolagus cuniculus cAMP-dependent protein kinase alpha-catalytic subunit 351 aa 25.8% 318 aa Compounds References
Bos taurus Casein kinase I isoform alpha 325 aa 24.7% 356 aa Compounds References
Xenopus laevis Aurora kinase B-B 368 aa 28.4% 306 aa Compounds References
Bos taurus cAMP-dependent protein kinase alpha-catalytic subunit 351 aa 27.0% 319 aa Compounds References
Rattus norvegicus cAMP-dependent protein kinase alpha-catalytic subunit 351 aa 27.0% 319 aa Compounds References
Homo sapiens Cyclin-dependent kinase 1/cyclin B1 297 aa 26.5% 253 aa Compounds References
Xenopus laevis Aurora kinase B-A 361 aa 29.1% 306 aa Compounds References
Plasmodium falciparum (isolate 3D7) Cell division control protein 2 homolog 288 aa 24.7% 287 aa Compounds References
Rattus norvegicus Serine/threonine-protein kinase pim-3 326 aa 30.2% 285 aa Compounds References

Obtained from network model

Ranking Plot


Putative Drugs List


Compound Raw Global Species
0.0023 0.5 0.5
0.0012 0.5 0.5
0.0091 1 0.5
0.0029 0.5 0.5
0.0064 0.3377 0
0.0039 0.5 0.5
0.0042 0.5 0.5
0.0059 1 1
0.0011 1 0.5
0.0088 0.4477 0.5
0.0098 0.3242 0.2614
0.0016 0.5 0.5
0.0008 0.5 0.5
0.0027 1 0.5
0.0012 0.5 0.5
0.0061 0.6883 0.5304
0.0067 0.5 0.5
0.0059 1 1
0.0036 0.5 0.5
0.0092 1 0.5
0.0016 0.5 0.5
0.0063 0.7244 0.2543
0.0066 0.3101 0
0.0037 1 0.5
0.0062 0.6935 0
0.0026 0.5 0.5
0.0093 0.8828 0
0.0032 0.5 0.5
0.0033 1 0.5
0.0012 0.5 0.5
0.0007 0.5 0.5
0.0007 0.5 0.5
0.0032 0.5 0.5
0.0004 0.5 0.5
0.0039 0.5 0.5
0.0063 1 0.5
0.0003 0.5 0.5
0.0039 0.9485 0.5
0.0033 0.5 0.5
0.0069 0.3067 1
0.0022 0.5 0.5
0.0056 1 0.5
0.0059 1 1
0.0018 0.5 0.5
0.0081 0.5 0.5
0.0007 0.5 0.5
0.0081 1 0.5

Assayability

Assay information

No assay information for this target.

Reagent availability

No reagent availability information for this target.

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this gene, please enter them in a user comment (below) or Contact us.

User comments

No user comments are available for this gene. Log in to add comments, or register.

Enter your comment

User ()
Gene identifier Tb11.v5.0190 (Trypanosoma brucei), protein kinase, putative
Title for this comment
Comment